Has David Lindenberg, DO received payments from drug or device companies?

Yes. Drug and device makers reported $7,434 in general payments to David Lindenberg, DO across 298 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Lindenberg, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Lindenberg, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Lindenberg, DO

Pain Medicine · Turlock, CANPI 1881909141

Payments from drug & device makers

$7,434in general payments, 2019–2025

Across 298 payments — averaging $24.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$3K
Painteq LLC$604
AbbVie$570
Si-bone, Inc.$358
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$245
Biohaven Pharmaceuticals, Inc.$238
plus $2K from 32 others

What the payments were for

Travel & lodging$79511%
Food & beverage$6,59789%
Education$421%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	140	$3,491
Painteq LLC	5	$604
AbbVie(2 entities)	33	$570
Si-bone, Inc.	8	$358
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	15	$245
Biohaven Pharmaceuticals, Inc.	9	$238
Amgen(2 entities)	7	$207
Collegium Pharmaceutical, Inc.	12	$194
Medtronic(2 entities)	5	$184
Nevro Corp.	6	$158
Scilex Pharmaceuticals Inc.	7	$130
Pfizer	8	$116
Biotronik NRO, Inc.	3	$106
Abbott	2	$86
Biohaven Pharmaceutical Holding Company Ltd.	4	$74
Hikma Pharmaceuticals USA	3	$61
Electronic Waveform Lab, Inc.	2	$55
Vertex	3	$54
Saluda Medical Americas, Inc.	2	$54
Daiichi Sankyo Inc.	3	$41
Merz Pharmaceuticals, LLC	2	$40
Bioventus LLC	2	$38
MML US, Inc.	1	$37
Avanos Medical	1	$36
Forte Bio-pharma LLC	2	$28
Teva Pharmaceuticals USA, Inc.	1	$27
Lundbeck LLC	1	$24
Stimwave Technologies Incorporated	1	$19
Biodelivery Sciences International, Inc.	1	$18
Averitas Pharma Inc.	1	$18
Nalu Medical, Inc.	1	$18
Novartis	1	$17
Shionogi Inc	1	$17
Pacira Pharmaceuticals Incorporated	1	$16
Eisai Inc.	1	$15
SPR Therapeutics, Inc	1	$14
Spinal Simplicity, LLC	1	$14
Metacel Pharmaceuticals LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,434 in reported general payments places this provider in the 75th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$2,458,982

Medicare patients

1,503

Services billed

55,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	188	$4,328
Naloxone Hcl	63	$3,342
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	75	$2,543
Lidocaine	20	$1,702
Gabapentin	98	$1,298
Pregabalin	27	$641
Fentanyl	12	$613
Duloxetine Hcl	29	$331
Tramadol Hcl	38	$250
Acetaminophen-CodeineAcetaminophen With Codeine	13	$195
Meloxicam	23	$171
Cyclobenzaprine Hcl	26	$152
Methocarbamol	13	$140

Paid to pharmacies, not to this prescriber.

Other pain medicine in Turlock

Eric GrigsbyNapa$3.2M
Jason PopeSanta Rosa$2.8M
Javid GhandehariSanta Monica$2.7M
Alexander HerselThousand Oaks$2.1M
Krishnan ChakravarthyTemecula$1.9M
Kasra AmirdelfanWalnut Creek$1.7M
Ramana NaiduLarkspur$1.6M
Foead GeulaStudio City$1.3M
Xiang QianRedwood City$941K
Jacqueline WeisbeinNapa$863K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →